CAS: 144-83-2; 4-Amino-N-(Pyridin-2-yl)Benzenesulfonamide

该化合物是一种属于被称为硫磺药物的化合物类的磺胺抗生素,其特点是它能够通过干扰对细菌代谢至关重要的叶酸合成来抑制细菌生长,其特点是它能够抑制细菌生长;硫丙胺的化学结构包括一个环和磺酰胺组,这增加了它的药理特性;它通常用于治疗炎炎肠病,如溃疡和克罗恩的疾病,因为其具有抗炎作用;硫丙胺在水中溶解,在标准条件下表现出中度稳定;其行动机制涉及对对丙烯二氢丙烯酸合成酶的竞争性抑制,这对细菌中的叶酸合成至关重要;虽然它有效,但硫丙烯可产生副作用,包括过敏反应和胃肠紊乱;与其他磺胺一样,对于具有肺炎过敏史的病人,告诫要谨慎.

结构式图片

欧盟法规

REACH注册ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号19077-98-6 N-[4-(2-Pyridin... | CAS号504-29-0 2-氨基吡啶 | CAS号121-60-8 对乙酰氨基苯磺酰氯 | CAS号1028-11-1 4-NITRO-N-2-PYR... | CAS号1213-38-3 4-氯-N-(吡啶-2-基)苯磺酰胺 | CAS号98-74-8 4-硝基苯磺酰氯 | CAS号98-62-4 4-氨基苯磺酰氟 | CAS号109-04-6 2-溴吡啶 | CAS号63-74-1 磺胺 | CAS号5029-67-4 2-碘吡啶 | CAS号39588-26-6 咪唑并[1,2-a]吡啶-2-胺 | CAS号19077-98-6 N-[4-(2-Pyridin... | CAS号504-29-0 2-氨基吡啶 | CAS号722-27-0 4,4'-二硫代二苯胺 | CAS号6325-93-5 4-硝基苯磺酰胺 | CAS号63-74-1 磺胺 | CAS号121-57-3 对氨基苯磺酸 | CAS号29821-91-8 Benzenesulfonam... | CAS号29817-71-8 Benzenesulfonam...

合成工艺路线路线简述

    N-硝基-N-吡啶-2-基苯磺酰胺置于铁粉,氯化铵体系中,用 甲醇 用作溶剂,化学反应 3.0H,以81%的收率获得磺胺吡啶
    参考文献:一种对氨基苯磺酰胺化合物的制备方法
    标题:一种对氨基苯磺酰胺化合物的制备方法
    摘要:本发明属于有机合成技术领域和磺胺类药物领域,具体公开了一种对氨基苯磺酰胺化合物的制备方法.所述制备方法具体包括以下步骤:将对硝基苯二硫醚和杂芳胺化合物在催化剂,氧化剂和溶剂条件下反应,制得对硝基苯磺酰胺;将对硝基苯磺酰胺在还原剂和溶剂条件下反应,得到对氨基苯磺酰胺化合物.本发明采用廉价的锆盐和铜盐作为催化剂,直接用稳定低毒的二硫醚作为磺酰化试剂,直接对胺进行磺酰化,常压下即可完成,避免制备磺酰氯这一步骤,也就避免了氯气和二氯亚砜等强腐蚀性物种的使用,方法更加简单,环保,符合当前世界发展绿色化工的要求.

    海关参考信息

    专利信息


    专利号:US-10768157-B2
    优先权日:2015-10-20
    标 题:Materials and methods for the detection of trace amounts of substances in biological and environmental samples
    发明人:KABIR ABUZAR; FURTON KENNETH G
    权利人:KABIR ABUZAR; FURTON KENNETH G; THE FLORIDA INTERNATIONAL UNIV BOARD OF TRUSTEES
    摘要:The subject invention provides chemical compositions and synthesis strategies to create molecularly imprinted polymers (MIPs) via sol-gel processes. In a specific embodiment, the subject invention utilizes a(n) organic, inorganic, or metallic template analyte to create a hybrid organic-inorganic or inorganic three-dimensional network possessing cavities complementary to the shape, size, and functional orientation of the template molecule or ions. The subject invention further pertains to the use of the novel MIPs as selective solid phase extraction (SPE) sorbents for pre-concentration and clean-up of trace substances in biological and environmental samples. Synthesis of other molecularly imprinted polymers with environmental, pharmaceutical, chemical, clinical, toxicological, and national security implications can be conducted in accordance with the teachings of the subject invention.

    专利号:US-8557979-B2
    优先权日:2004-06-10
    标题 :Carbapenem antibacterials with gram-negative activity and processes for their preparation
    发明人:CHOI WOO-BAEG; KOWALIK EWA
    权利人:CHOI WOO-BAEG; KOWALIK EWA; FOB SYNTHESIS INC
    摘要:The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment. The present invention is also in the field of synthetic organic chemistry and is specifically provides an improved method of synthesis of β-methyl carbapenems which are useful as antibacterial agents.

    专利号:US-10933051-B2
    优先权日:2017-06-09
    标 题 :Carbapenem compounds and compositions for the treatment of bacterial infections
    发明人:CHOI WOO-BAEG; TOMIOKA TAKASHI; JOO HYUNG-YEUL; TRUONG PHONG; MIN BRIAN
    权利人:FOB SYNTHESIS INC
    摘要:The present invention provides carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections, including drug resistant or multiple-drug resistant bacterial infections, and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment.

    专利号:US-8754197-B2
    优先权日:2004-07-07
    标题:Synthesis of azo bonded immunoregulatory compounds
    发明人:RIGGS-SAUTHIER JENNIFER A; EKWURIBE NNOCHIRI N
    权利人:RIGGS-SAUTHIER JENNIFER A; EKWURIBE NNOCHIRI N; BIOCON LTD
    摘要:Methods are disclosed for preparing compounds of Formula I: n nwhere R 1 , R 3 , and R 4 are independently hydrogen or C 1 to C 4 alkyl, and R 2 is:n n nwhere R 5 is selected from the group consisting of hydrogen and C 1 to C 4 alkyl, orn n nwhere R 6 , R 7 and R 8 are independently hydrogen or C 1 to C 4 alkyl; or the esters or pharmacologically acceptable salts thereof. The compounds and or their metabolites can be used to treat or prevent various diseases, particularly inflammatory conditions of the GI tract.

    专利号:US-9439423-B2
    优先权日:2007-10-29
    标 题 :Antiparasitic agent for fish and method of controlling proliferation of fish parasites
    发明人:KAWANO FUMI; HIRAZAWA NORITAKA
    权利人:KAWANO FUMI; HIRAZAWA NORITAKA; NIPPON SUISAN KAISHA LTD
    摘要:An antiparasitic agent for fish includes an inhibitor of folate synthesis and/or an inhibitor of folate activation as the active substance(s). A combination preparation composed of an inhibitor of folate synthesis and an inhibitor of folate activation is disclosed. Sulfonamide is disclosed as suitable for the inhibitor of folate synthesis. A dihydrofolate reductase inhibitor, a folate antagonist are disclosed as suitable inhibitors of folate activation. The antiparasitic agent is able to exterminate fish parasites via oral administration. It is effective against fish parasites belonging to the ciliate group.

    专利号:US-6858434-B1
    优先权日:1999-10-06
    标 题:Method for synthesis, separation and screening of a plurality of compounds in the same bulk of a stationary phase
    发明人:WILLIAMS LORENZO
    权利人:SINVENT AS
    摘要:A method for sequentially performing a synthesis, separation and screening of chemical entities, especially a combinatorial library, is described. The method utilises a bulk of a stationary phase (e.g. silica gel, aluminium oxide, cellulose, etc. for example arranged on a backing) for the performance of the synthesis, separation and screening. The technique described enables a rapid route from synthesis to the testing of chemical compounds. Screening can be performed without need for reaction work-up. Preferred screening methods are those used to determine the biological activity of the compounds.
    南通嘉星泰生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jxtbio.com
    企业联系电话:18795782766;13773776703👤
    📞南通嘉星泰生物科技有限公司 ⚠️参考联系方式
    联系人:蔡先生
    电话:18795782766;13773776703

    传真:0513-87503981
    邮箱:297962169@qq.com
    通信地址: 江苏省如皋市石庄镇张扬园村十组42号
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省如皋市石庄镇张扬园村十组42号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Sobolewska B, Deuter C, Zierhut M. Current medical treatment of ocular mucous membrane pemphigoid. Ocul Surf. 2013 Oct;11(4):259-66. doi: 10.1016/j.jtos.2013.02.003. Epub 2013 Jul 9. Review. doi: 10.4137/CGast.S8673. eCollection 2012. Review.
    3: Intong LR, Murrell DF. Management of epidermolysis bullosa acquisita. Dermatol Clin. 2011 Oct;29(4):643-7. doi: 10.1016/j.det.2011.06.020. Epub 2011 Aug 15. Review. doi: 10.1016/j.det.2011.06.015. Epub 2011 Aug 3. Review. doi: 10.1016/j.annder.2011.01.010. Review. French. doi: 10.1097/MCG.0b013e3181db1a61. Review. doi: 10.1086/591399. Review. doi: 10.1007/s10620-008-0481-x. Epub 2008 Sep 4. Review. Report of the IWGT working group on strategy/interpretation for regulatory in vivo tests II. Identification of in vivo-only positive compounds in the bone marrow micronucleus test. Mutat Res. 2007 Feb 3;627(1):92-105. Epub 2006 Nov 20. Review.
    10: Hanauer SB. Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis. Aliment Pharmacol Ther. 2006 Oct;24 Suppl

    合成参考文献


    参考文献:10.1016/j.jaci.2009.10.031
    摘要:Castrejon JL, Berry N, El-Ghaiesh S, Gerber B, Pichler WJ, Park BK, Naisbitt DJ. Stimulation of human T cells with sulfonamides and sulfonamide metabolites. Journal of Allergy and Clinical Immunology. 2010 Feb;125(2):411–418.e4. doi: 10.1016/j.jaci.2009.10.031.
    参考文献:10.1007/s10350-005-0210-x
    摘要:Dozois EJ, Wolff BG, Tremaine WJ, Watson WJ, Drelichman ER, Carne PWG, Bakken JL. Maternal and Fetal Outcome After Colectomy for Fulminant Ulcerative Colitis During Pregnancy: Case Series and Literature Review. Diseases of the Colon & Rectum. 2005 Dec 02;49(1):64–73. doi: 10.1007/s10350-005-0210-x.
    参考文献:10.1107/s1600536811019490
    摘要:Gelbrich T, Haddow MF, Griesser UJ. Benzyl-sulfamide. Acta Crystallogr Sect E Struct Rep Online. 2011 Jun 01;67(Pt 6):o1551–2.
    参考文献:10.1136/gut.2005.077461
    摘要:Rust C, Bauchmuller K, Bernt C, Vennegeerts T, Fickert P, Fuchsbichler A, Beuers U. Sulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers. Gut. 2006 May;55(5):719–27.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知